Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
5
100%

Phase Distribution

5

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
5(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 15 (100.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials
Showing 5 of 5
completedphase_1

Study Evaluating the Pharmacokinetics of HCV-796 in Healthy Japanese Men

NCT00385190
completedphase_1

Study Evaluating the Pharmacokinetics of the Potential Drug Interaction Between HCV-796 and Desipramine

NCT00500721
completedphase_1

Study to Evaluate the Effects of Age & Gender on PK, Safety & Tolerability of HCV-796 Administered to Healthy Subjects

NCT00407173
completedphase_1

Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults

NCT00314054
completedphase_1

HCV-796 and Midazolam Drug Interaction Study in Healthy Subjects

NCT00410254

Clinical Trials (5)

Showing 5 of 5 trials
NCT00385190Phase 1

Study Evaluating the Pharmacokinetics of HCV-796 in Healthy Japanese Men

Completed
NCT00500721Phase 1

Study Evaluating the Pharmacokinetics of the Potential Drug Interaction Between HCV-796 and Desipramine

Completed
NCT00407173Phase 1

Study to Evaluate the Effects of Age & Gender on PK, Safety & Tolerability of HCV-796 Administered to Healthy Subjects

Completed
NCT00314054Phase 1

Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults

Completed
NCT00410254Phase 1

HCV-796 and Midazolam Drug Interaction Study in Healthy Subjects

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5